CYCN logo

Cyclerion Therapeutics, Inc. (CYCN)

Profile

Full Name

Cyclerion Therapeutics, Inc.

Ticker

NASDAQ: CYCN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 18, 2019

Indexes

Not included

Website

https://www.cyclerion.com

Employees

1

Key Details

Price

$2.34(+0.43%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.00M(+100.00% YoY)

Annual EPS

-$1.21(+46.22% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.34
    CYCN price is $2.34

    30-Day Relative Volume

    0.39
    CYCN 30-day relative volume is 0.39

    Price Performance

    Price Most recent change

    +0.43%
    CYCN price was up +0.43% on Sep 18, 2025

    Price YTD change

    -27.33%
    CYCN price is down -27.33% since January 1st

    Price 1-year change

    -16.73%
    CYCN price is down -16.73% year-on-year

    Price 3-year change

    -88.17%
    CYCN price is down -88.17% over the past 3 years

    Price Range

    Price All-time high

    $457.00
    CYCN price is currently -99.49% below its historical high of $457.00

    Price 3-year low

    $1.27
    CYCN price is currently +84.25% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.50M
    CYCN market capitalization is $7.50 million

    Market cap 3-year change

    -82.57%
    CYCN market capitalization is down -82.57% over the past 3 years

    Market cap All-time high

    $623.90M
    CYCN market capitalization is currently -98.80% below its historical high of $623.90 million

    Market cap sector rank

    12.26%
    CYCN market capitalization is higher than 12.26% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +27.32%
    CYCN shares outstanding is up +27.32% year-on-year

    Shares Outstanding 3-Year Change

    +47.35%
    CYCN shares outstanding is up +47.35% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.26
    CYCN beta is 0.26

    200-day SMA

    $2.96
    CYCN price is currently -20.94% below its 200-day simple moving average

    50-day SMA

    $2.66
    CYCN price is currently -11.93% below its 50-day simple moving average

    RSI

    45.48
    CYCN 14-day relative strength index is 45.48

    Volume

    0.39
    CYCN 30-day relative volume is 0.39

    ATR

    $0.22
    CYCN average true range is $0.22

    10-day Historical Volatility

    117.68%
    CYCN 10-day historical volatility is 117.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.00M
    CYCN annual revenue is $2.00 million

    Revenue Analysts estimate

    $2.04M
    CYCN annual revenue is currently -1.96% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    CYCN annual revenue is up +100% year-on-year

    Revenue Sector rank

    39.2%
    CYCN annual revenue is higher than 39.2% of companies in Healthcare sector

    EPS

    EPS

    -$1.21
    CYCN annual earnings per share is -$1.21

    EPS Analysts estimate

    -
    CYCN annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +46.22%
    CYCN annual earnings per share is up +46.22% year-on-year

    EPS Sector rank

    47.52%
    CYCN annual earnings per share is higher than 47.52% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    CYCN annual gross profit is $0.00

    Gross margin

    0.00%
    CYCN annual gross profit margin is 0.00%

    Operating profit

    -$3.63M
    CYCN annual operating income is -$3.63 million

    Operating margin

    -181.40%
    CYCN annual operating profit margin is -181.40%

    Net income

    -$3.06M
    CYCN annual net profit is -$3.06 million

    Net margin

    -152.85%
    CYCN annual net profit margin is -152.85%

    Expenses

    Total expenses

    $5.06M
    CYCN annual total expenses is $5.06 million

    Operating expenses

    $3.63M
    CYCN annual total operating expenses is $3.63 million

    Cost of goods sold

    -
    CYCN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $0.00
    CYCN annual SGA is $0.00

    Depreciation and amortization

    $0.00
    CYCN annual depreciation & amortization is $0.00

    Interest expense

    $0.00
    CYCN annual interest expense is $0.00

    Income tax

    $0.00
    CYCN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$3.63M
    CYCN annual earnings before interest & taxes is -$3.63 million

    EBITDA

    -$3.63M
    CYCN annual EBITDA is -$3.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $9.57M
    CYCN annual total assets is $9.57 million

    Non current assets

    $5.35M
    CYCN annual long term assets is $5.35 million

    Current assets

    $4.22M
    CYCN annual total current assets is $4.22 million

    Cash and cash equivalents

    $3.23M
    CYCN annual cash & cash equivalents is $3.23 million

    Accounts receivable

    $556.00K
    CYCN annual accounts receivable is $556.00 thousand

    Inventory

    $0.00
    CYCN annual inventory is $0.00

    Liabilities

    Total liabilities

    $725.00K
    CYCN annual total liabilities is $725.00 thousand

    Long term liabilities

    $0.00
    CYCN annual total long term liabilities is $0.00

    Current liabilities

    $725.00K
    CYCN annual total current liabilities is $725.00 thousand

    Accounts payable

    $390.00K
    CYCN annual accounts payable is $390.00 thousand

    Debt

    Total debt

    $0.00
    CYCN annual total debt is $0.00

    Total debt 1-year change

    0%
    CYCN annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    CYCN annual long term debt is $0.00

    Short term debt

    $0.00
    CYCN annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $8.85M
    CYCN annual stockholders equity is $8.85 million

    Book value

    $8.85M
    CYCN annual book value is $8.85 million

    Retained earnings

    -$267.49M
    CYCN annual retained earnings is -$267.49 million

    Working capital

    $3.50M
    CYCN annual working capital is $3.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$4.33M
    CYCN annual cash flow from operations is -$4.33 million

    Cash from operations 1-year change

    +79.6%
    CYCN annual cash flow from operations is up +79.6% year-on-year

    Cash from investing

    $0.00
    CYCN annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    CYCN annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $0.00
    CYCN annual cash flow from financing activities is $0.00

    Cash from financing 1-year change

    -100%
    CYCN annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $0.00
    CYCN annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    CYCN annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$4.33M
    CYCN annual free cash flow is -$4.33 million

    Free cash flow 1-year change

    +79.6%
    CYCN annual free cash flow is up +79.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    0.00%
    CYCN annual gross profit margin is 0.00%

    Operating margin

    -181.40%
    CYCN annual operating profit margin is -181.40%

    Net margin

    -152.85%
    CYCN annual net profit margin is -152.85%

    ROA & ROE

    ROA

    -26.64%
    CYCN annual return on assets is -26.64%

    ROE

    -30.36%
    CYCN annual return on equity is -30.36%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CYCN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CYCN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.87
    CYCN price to book ratio is 0.87

    PB ratio Sector rank

    31.51%
    CYCN price to book ratio is higher than 31.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.45
    CYCN price to sales ratio is 3.45

    PS ratio Sector rank

    48.45%
    CYCN price to sales ratio is higher than 48.45% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.49M
    CYCN enterprise value is $4.49 million

    Enterprise value Sector rank

    17.1%
    CYCN enterprise value is higher than 17.1% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.20
    CYCN EV/EBITDA is -1.20

    EV/EBITDA Sector rank

    45.19%
    CYCN EV/EBITDA is higher than 45.19% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.83
    CYCN annual current ratio is 5.83

    Quick ratio

    5.83
    CYCN annual quick ratio is 5.83

    Leverage

    Debt to equity

    0.00
    CYCN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CYCN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CYCN piotroski f-score value is unknown

    Altman Z-Score

    -33.51
    CYCN altman z-score is -33.51

    Analyst ratings

    Recent major analysts updates

    Oct 20, 21 Truist Securities
    Buy
    Sep 24, 21 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with CYCN included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Cyclerion Therapeutics, Inc.?
    • Does Cyclerion Therapeutics, Inc. pay dividends?
    • What sector is Cyclerion Therapeutics, Inc. in?
    • What industry is Cyclerion Therapeutics, Inc. in?
    • What country is Cyclerion Therapeutics, Inc. based in?
    • When did Cyclerion Therapeutics, Inc. go public?
    • Is Cyclerion Therapeutics, Inc. in the S&P 500?
    • Is Cyclerion Therapeutics, Inc. in the NASDAQ 100?
    • Is Cyclerion Therapeutics, Inc. in the Dow Jones?
    • When was Cyclerion Therapeutics, Inc.'s last earnings report?
    • When does Cyclerion Therapeutics, Inc. report earnings?

    What is the ticker symbol for Cyclerion Therapeutics, Inc.?

    The ticker symbol for Cyclerion Therapeutics, Inc. is NASDAQ:CYCN

    Does Cyclerion Therapeutics, Inc. pay dividends?

    No, Cyclerion Therapeutics, Inc. does not pay dividends

    What sector is Cyclerion Therapeutics, Inc. in?

    Cyclerion Therapeutics, Inc. is in the Healthcare sector

    What industry is Cyclerion Therapeutics, Inc. in?

    Cyclerion Therapeutics, Inc. is in the Biotechnology industry

    What country is Cyclerion Therapeutics, Inc. based in?

    Cyclerion Therapeutics, Inc. is headquartered in United States

    When did Cyclerion Therapeutics, Inc. go public?

    Cyclerion Therapeutics, Inc.'s initial public offering (IPO) was on March 18, 2019

    Is Cyclerion Therapeutics, Inc. in the S&P 500?

    No, Cyclerion Therapeutics, Inc. is not included in the S&P 500 index

    Is Cyclerion Therapeutics, Inc. in the NASDAQ 100?

    No, Cyclerion Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Cyclerion Therapeutics, Inc. in the Dow Jones?

    No, Cyclerion Therapeutics, Inc. is not included in the Dow Jones index

    When was Cyclerion Therapeutics, Inc.'s last earnings report?

    Cyclerion Therapeutics, Inc.'s most recent earnings report was on August 5, 2025

    When does Cyclerion Therapeutics, Inc. report earnings?

    The next expected earnings date for Cyclerion Therapeutics, Inc. is November 14, 2025
    On this page